Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Example of evaluation parameter set for case #1

From: Impact of beam configuration on VMAT plan quality for Pinnacle3Auto-Planning for head and neck cases

Structure DVH Parameter   Dose Limit in relation to D95 Absolute Dose
Limit in Gy
PTV1 D95   ± 2% 69,30
D98 > 0,95 D95 65,8
Dmin > 0,9 D95 62,4
STD < 3,3% 2,3
PTV2 D95   ± 2% 66,00
D98 > 0,95 D95 62,7
Dmin > 0,9 D95 59,4
STD < 3,3% 2,2
PTV3 D95 > ± 2% 59,40
D98 > 0,95 D95 56,4
Dmin < 0,9 D95 53,5
STD < 3,3% 2,0
SpinalCanal D 1cm3 <   45
BrainStem D 1cm3 <   45
Left Parotid D66 <   20
Dmean <   26
Right Parotid D66 <   20
Dmean <   26
Larynx D05 <   69
D05 <   45
Mandible D05 <   69
D10 <   60
D50 <   52
Neck Dmax <   40
Left Lens D05 <   9
Right Lens D05 <   9
Left OpticNerve D05 <   50
Right OpticNerve D05 <   50
Chiasm D05 <   50
Pituitary D05 <   50
Left InnerEar D05 <   30
Right InnerEar D05 <   30
Outline DMax < 1,15 D95 79,7
  1. Definition of an evaluation parameter set for an integrated boost technique with three dose levels (PTV1, PTV2, PTV3). Requirements for target coverage and dose homogeneity are described by DVH parameters, relative and absolute dose limits scaled according to the prescription dose D95 of each PTV (top part). DVH parameters and absolute dose limits are listed for organs at risk (bottom part)
  2. DMin Minimum Dose, DMax Maximum Dose, DMean Mean Dose, STD Standard deviation, DX Volume X is covered by the dose value, PTV Planning target volume